Key result
MADIT II-eligible Japanese patients without ICDs show low mortality, with only ~17% death rate over 37 months.
Why the study?
It is unclear whether the MADIT II criteria for ICD implantation are appropriate for Japanese patients with prior MI and reduced LVEF.
Are the MADIT II criteria for prophylactic ICD implantation appropriate for Japanese patients?
Cohort (n=90)
No
Are the MADIT II criteria for prophylactic ICD implantation appropriate for Japanese patients?
Applying MADIT II criteria to Japanese patients may be inappropriate, as their baseline survival on conventional therapy is already comparable to the ICD arm of the MADIT II trial.
Answers are grounded in this paper and cite their sources.
Questions applicability of MADIT II criteria in Japanese patients; leaves open need for population-specific validation before broader use.
BACKGROUND: The Multicenter Automatic Defibrillator Implantation Trial (MADIT) II investigators concluded that prophylactic use of an implantable cardioverter defibrillator (ICD) improved survival in patients with prior myocardial infarction (MI) and reduced the left ventricular ejection fraction (LVEF). However, it is unclear whether MADIT II criteria for ICD implantation are appropriate for Japanese patients. METHODS AND RESULTS: During the period 1997 to 2001 90 (M/F: 75/15; mean age: 65+/-9 years) of the 3,258 patients who underwent elective cardiac catheterization met MADIT II criteria (Q-wave MI more than 4 weeks prior; LVEF 21 years of age; electrophysiologic testing not required) and were selected in this retrospective study of patient prognosis after catheterization. During the 37+/-12-month follow-up period, 15 patients died of congestive heart failure (n=9), sudden cardiac death (n=2), acute MI (n=1), or noncardiac causes (n=3). The survival rate in the present series was comparable with that in the MADIT II defibrillator group, but higher than that in the MADIT II conventional therapy group. A significantly greater percentage of the present patients were found to be in New York Heart Association class I and have undergone percutaneous coronary intervention than in MADIT II. CONCLUSION: These results suggest that it may be inappropriate to apply MADIT II criteria to Japanese patients.
No takes yet. Share an insight, caveat, or question.
Tanno et al. (2004) conducted a cohort in Prior myocardial infarction with left ventricular dysfunction (n=90). Conventional therapy without ICD vs. MADIT II trial patients (historical) was evaluated on All-cause mortality. Japanese patients meeting MADIT II criteria who did not receive an ICD had a 16.7% mortality rate over 37 months, showing survival comparable to the MADIT II defibrillator group and better than the conventional therapy group.
Synapse has enriched 10 related papers. Consider them for comparative context: